Comments
Loading...

OncoCyte

OCXNASDAQ
Logo brought to you by Benzinga Data
$2.19
-0.02-0.90%
At close: -
$2.19
0.000.00%
After Hours: Dec 20, 4:03 PM EDT

OncoCyte (NASDAQ:OCX) Stock, Insider Trading Activity

OncoCyte: Insider buying and selling updated today.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are OncoCyte Corp Insiders Doing?

At OncoCyte Corp, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 20.00K shares for a total value of $45.80K.

Notable Recent Insider Buys and Sales

  • On October 4, 2024, BROADWOOD PARTNERS LP, BROADWOOD CAPITAL INC, NEAL BRADSHER, the company's 10% OWNER purchased 1.32M shares for $2.95 each.
  • On October 4, 2024, Andrea James, the company's CHIEF FINANCIAL OFFICER purchased 33.67K shares for $2.97 each.
  • On December 9, 2024, Andrea James, the company's CHIEF FINANCIAL OFFICER purchased 20K shares for $2.29 each.

Ownership Statistics for OncoCyte Corp

Shares Outstanding
16.835M
Insider Shares Owned
7.072M
Insider Percentage Owned
42.0%
Institutional Shares Held
513.127K
Institutional Percentage Held
3.05%
Data brought to you by Benzinga APIs

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch